Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: a prospective

Lisa Ternström1, Vladimir Radulovic, Martin Karlsson

  • 1Department of Cardiovascular Surgery and Anesthesia, Sahlgrenska University Hospital, Gothenburg, Sweden.

Thrombosis Research
|June 29, 2010
PubMed

Insights

Coagulation factor levels change significantly after coronary artery bypass grafting (CABG). Lower fibrinogen and Factor XIII activity correlate with increased postoperative bleeding in CABG patients.

Area of Science:

  • Cardiovascular Surgery
  • Hematology
  • Coagulation Science

Background:

  • Cardiopulmonary bypass during CABG can lead to hemodilution and consumption of coagulation factors.
  • This may contribute to bleeding complications observed post-cardiac surgery.

Purpose of the Study:

  • To investigate the activity of individual coagulation factors following CABG.
  • To assess the relationship between coagulation factor activity, hemodilution, and postoperative bleeding.

Main Methods:

  • Analyzed plasma concentrations of fibrinogen and activity of factors II, V, VII, VIII, IX, X, XI, and XIII in 57 CABG patients.
  • Measurements were taken before, 2 hours, and 24 hours after surgery, adjusted for hemodilution.
  • Correlated coagulation factor activity with registered postoperative bleeding volumes.

Main Results:

  • Significant reductions in fibrinogen, Factors II, V, X, and XIII were observed 2 hours post-surgery.
  • Factors VIII and IX showed increased activity post-surgery, while FVII and FXI remained unchanged.
  • Twenty-four hours post-surgery, fibrinogen, Factor VIII, and Factor IX levels increased, while FVII, FXI, and FXIII decreased.
  • Postoperative blood loss correlated inversely with fibrinogen levels at 2 hours and Factor XIII activity (pre- and post-surgery).

Conclusions:

  • Coagulation factor activity exhibits significant dissociation after CABG.
  • Fibrinogen concentration and Factor XIII activity are key predictors of reduced postoperative bleeding after CABG.
Abstract

Related Concept Videos

Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...